Prosecution Insights
Last updated: October 01, 2026
Application No. 18/887,711

HUMIDIFICATION SYSTEM

Non-Final OA §102§112
Filed
Sep 17, 2024
Priority
Mar 30, 2012 — provisional 61/618,573 +4 more
Examiner
HOBSON, STEPHEN
Art Unit
Tech Center
Assignee
Fisher & Paykel Healthcare Limited
OA Round
1 (Non-Final)
65%
Grant Probability
Favorable
1-2
OA Rounds
11m
Est. Remaining
86%
With Interview

Examiner Intelligence

Grants 65% — above average
65%
Career Allowance Rate
411 granted / 628 resolved
+5.4% vs TC avg
Strong +20% interview lift
Without
With
+20.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 0m
Avg Prosecution
50 currently pending
Career history
674
Total Applications
across all art units

Statute-Specific Performance

§101
0.5%
-39.5% vs TC avg
§103
49.3%
+9.3% vs TC avg
§102
17.5%
-22.5% vs TC avg
§112
31.6%
-8.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 628 resolved cases

Office Action

§102 §112
DETAILED CORRESPONDENCE Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112(b) Claim 28 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 28 recites “the compressible volume of the humidification chamber should be reduced when used with a neonatal patient when compared to an adult patient”. It is unclear what is being claimed and if the claim requires the compressible volume to be reduced. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of pre-AIA 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a) the invention was known or used by others in this country, or patented or described in a printed publication in this or a foreign country, before the invention thereof by the applicant for a patent. Claims 17-32 are rejected under pre-AIA 35 U.S.C. 102(a)(1) as being anticipated by Roberts et al. US 5,388,571 (hereafter Roberts). Regarding claim 17, Roberts teaches a respiratory humidification system (Fig 1) comprising: a pump (190) configured to be in fluid communication with a humidification chamber (150), the humidification chamber comprising outer walls (walls shown in Fig 1), the outer walls defining a cavity (space within component 150), the cavity being configured to contain a quantity of liquid (liquid medicine in region 162), the cavity defining a fixed overall volume (where the volume will not change), the fixed overall volume comprising a compressible volume (volume above liquid) and a volume (volume of liquid in Fig 1) of liquid (col 8 lines 25-56); wherein the pump is configured to remove liquid from the cavity such that the compressible volume of the humidification chamber can be increased by removing liquid and such that the compressible volume of the humidification chamber can be decreased by adding liquid (col 8 lines 25-56, where the pump removes liquid to increase the compressible volume, where the structure of the valve 182 is fully capable of adding liquid to decrease the compressible volume, see MPEP 2114, 2115, 2173.05(g)). Regarding claim 18, Roberts teaches all the limitations of claim 17. Roberts further teaches wherein the pump comprises a pump conduit (188) fluidly connected to the cavity. Regarding claim 19, Roberts teaches all the limitations of claim 18. Roberts further teaches a reservoir (190, col 8 lines 48-56), the reservoir being fluidly connected to the cavity with a reservoir conduit. Regarding claim 20, Roberts teaches all the limitations of claim 19. Roberts further teaches wherein the pump transports the liquid removed from the cavity through the reservoir conduit to the reservoir (col 8 lines 25-56). Regarding claim 21, Roberts teaches all the limitations of claim 19. Roberts further wherein the liquid removed from the cavity is discarded (col 8 lines 25-56). Regarding claim 22, Roberts teaches all the limitations of claim 19. Roberts further wherein a portion of liquid removed from the cavity is discarded while a portion of liquid removed from the cavity is stored in the reservoir (col 8 lines 25-56 where the system of Roberts is fully capable of discarding one portion and storing another, see MPEP 2114, 2115, 2173.05(g)). Regarding claims 25 and 27-28, Roberts teaches all the limitations of claim 17. Roberts further teaches wherein removing liquid from the cavity enables the fixed overall volume to be adapted to patients requiring respiratory therapy of different tidal volumes or frequencies (where the structure of Roberts is fully capable of performing the functional limitations in accordance with MPEP 2114, 2115, 2173.05(g)); wherein, when the respiratory humidification system is for use with adult patients, the pump is configured to increase the compressible volume of the humidification chamber (col 8 lines 25-56, where the increase would occur when removing fluid in an adult patient); wherein, when the respiratory humidification system is delivering a respiratory therapy of different tidal volumes or breath frequency, the compressible volume of the humidification chamber should be reduced when used with a neonatal patient when compared to an adult patient (where the structure of Roberts is fully capable of performing the functional limitations in accordance with MPEP 2114, 2115, 2173.05(g)). Regarding claims 17-19 and 23-24, Roberts teaches a respiratory humidification system (Fig 1) comprising: a pump (170) configured to be in fluid communication with a humidification chamber (150), the humidification chamber comprising outer walls (walls shown in Fig 1), the outer walls defining a cavity (space within component 150), the cavity being configured to contain a quantity of liquid (liquid medicine in region 162), the cavity defining a fixed overall volume (where the volume will not change), the fixed overall volume comprising a compressible volume (volume above liquid) and a volume (volume of liquid in Fig 1) of liquid (col 7 line 9 – col 8 line 18); wherein the pump is configured to add liquid from the cavity such that the compressible volume of the humidification chamber can be increased by removing liquid and such that the compressible volume of the humidification chamber can be decreased by adding liquid (col 7 line 9 – col 8 line 18, where the pump adds liquid to decrease the compressible volume, where the structure of the valve 176 is fully capable of removing liquid to decrease the compressible volume, see MPEP 2114, 2115, 2173.05(g)); wherein the pump comprises a pump conduit fluidly connected to the cavity (col 7 line 9 – col 8 line 18); a reservoir (170, col 7 line 9 – col 8 line 18), the reservoir being fluidly connected to the cavity with a reservoir conduit (174); wherein the pump transports the liquid to be added to the cavity via the reservoir conduit from the reservoir (col 7 line 9 – col 8 line 18); wherein the pump transports the liquid to be added to the cavity from a liquid source (170, col 7 line 9 – col 8 line 18). Regarding claims 17, 25, and 27-28, Roberts teaches a respiratory humidification system (Fig 1) comprising: a pump (170) configured to be in fluid communication with a humidification chamber (150), the humidification chamber comprising outer walls (walls shown in Fig 1), the outer walls defining a cavity (space within component 150), the cavity being configured to contain a quantity of liquid (liquid medicine in region 162), the cavity defining a fixed overall volume (where the volume will not change), the fixed overall volume comprising a compressible volume (volume above liquid) and a volume (volume of liquid in Fig 1) of liquid (col 7 line 9 – col 8 line 18); wherein the pump is configured to add liquid from the cavity such that the compressible volume of the humidification chamber can be increased by removing liquid and such that the compressible volume of the humidification chamber can be decreased by adding liquid (col 7 line 9 – col 8 line 18, where the pump adds liquid to decrease the compressible volume, where the structure of the valve 176 is fully capable of removing liquid to decrease the compressible volume, see MPEP 2114, 2115, 2173.05(g)); wherein adding liquid from the cavity enables the fixed overall volume to be adapted to patients requiring respiratory therapy of different tidal volumes or frequencies (where the structure of Roberts is fully capable of performing the functional limitations in accordance with MPEP 2114, 2115, 2173.05(g)); wherein, when the respiratory humidification system is for use with neonatal patients, the pump reduces the compressible volume of the humidification chamber (col 7 line 9 – col 8 line 18, where the decrease would occur when adding fluid in with a neonatal patient); wherein, when the respiratory humidification system is delivering a respiratory therapy of different tidal volumes or breath frequency, the compressible volume of the humidification chamber should be reduced when used with a neonatal patient when compared to an adult patient (where the structure of Roberts is fully capable of performing the functional limitations in accordance with MPEP 2114, 2115, 2173.05(g)). Regarding claim 29, Roberts teaches a respiratory humidification system (Fig 1) comprising: a pump (190) that is configured to fluidly connect to a conduit (180), the conduit forming at least a portion of a breathing circuit assembly (as shown in Fig 1); wherein the pump is configured to remove condensate from the conduit of the breathing circuit assembly (col 8 lines 25-56). Regarding claim 30, Roberts teaches all the limitations of claim 29. Roberts further teaches wherein the pump is configured to be connected at location along the conduit proximate to a patient interface such that the pump is configured to remove condensate from the breathing circuit assembly before condensate reaches a patient (as shown in Fig 1). Regarding claim 31, Roberts teaches all the limitations of claim 29. Roberts further teaches wherein the pump is configured to be connected to the conduit at a low point (162) in the breathing circuit assembly such that the pump is configured to remove condensate that may accumulate in the breathing circuit assembly at the low point (as shown in Fig 1; see MPEP 2114, 2115, 2173.05(g)). Regarding claim 32, Roberts teaches all the limitations of claim 31. Roberts further teaches wherein the pump is fluidly connected to a reservoir, the pump being configured to deposit condensate into the reservoir (col 8 lines 25-56). Related Art Applicant is made aware of US 2015/0250957 which teaches a system (Figs 2-3) comprising a pump (24) in fluid communication with a chamber (C in Fig 1) wherein the pump is configured to add or remove liquid from the cavity. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to STEPHEN HOBSON whose telephone number is (571)272-9914. The examiner can normally be reached 9am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer Dieterle can be reached at 571-270-7872. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /STEPHEN HOBSON/Examiner, Art Unit 1776
Read full office action

Prosecution Timeline

Sep 17, 2024
Application Filed
Sep 18, 2026
Non-Final Rejection mailed — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12746504
CARBON DIOXIDE REMOVAL APPARATUS
3y 0m to grant Granted Sep 29, 2026
Patent 12735370
CARBON DIOXIDE SEPARATION, COLLECTION, AND UTILIZATION SYSTEM AND CARBON DIOXIDE SEPARATION, COLLECTION, AND UTILIZATION METHOD
2y 9m to grant Granted Sep 15, 2026
Patent 12702943
MID-PRESSURE WATER SEPARATION FOR ENVIRONMENTAL CONTROL SYSTEM
2y 6m to grant Granted Aug 11, 2026
Patent 12697574
AIR FILTRATION SYSTEM AND SET OF PROFILES AND ACCESSORIES FOR SEALING AND CREATION OF A SEALED OR PARTIALLY SEALED ENVIRONMENT WITH CONTROLLED AIRFLOW
2y 7m to grant Granted Aug 04, 2026
Patent 12691407
METHOD FOR THE VOLATILE ORGANIC COMPOUNDS ADSORPTION CAPACITY PREDICTION BASED ON FILLING ADSORPTION
2y 2m to grant Granted Jul 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
65%
Grant Probability
86%
With Interview (+20.3%)
3y 0m (~11m remaining)
Median Time to Grant
Low
PTA Risk
Based on 628 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month